This cohort study reports the results of incorporating HIV screening into COVID-19 testing at the University of Chicago emergency department.
View Article and Find Full Text PDFBackground: The Papanicolaou (Pap) test is an effective, well-accepted screening tool that has led to a decrease in cervical cancer incidence and mortality. Updated evidence-based cervical cancer screening guidelines support less frequent testing in low-risk patients but have met resistance from providers and patients.
Aims: To assess patient knowledge about cervical cancer screening and attitudes toward recommendations for less frequent testing.